Clinical Trials Directory

Trials / Unknown

UnknownNCT03192592

Safety and Effectiveness Evaluation of the Apotech® Diabetic Body Moisturizer

Safety and Effectiveness Evaluation of a New Moisturizer Formulation With Antioxidant, Anti-inflammatory and Anti-microbial Effects in the Prevention of a Diabetic Skin Dryness and Complications

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
36 (actual)
Sponsor
ANS Pharma · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Safety and effectiveness evaluation of a new moisturizer formulation with antioxidant, anti-inflammatory and anti-microbial effects in the prevention of diabetics dry skin and complications.

Detailed description

Safety and effectiveness evaluation of a new moisturizer formulation with antioxidant, anti-inflammatory and anti-microbial effects in the prevention of diabetics dry skin and complications. This study aim to address the target population, subjects with controlled diabetes, to verify the improvement of texture, elasticity, and general appearance of the skin through the application of the cosmetic product Apotech®.

Conditions

Interventions

TypeNameDescription
OTHERBody moisturizerDaily body moisturizer application for skin protection and barrier.

Timeline

Start date
2017-05-02
Primary completion
2017-06-26
Completion
2017-07-28
First posted
2017-06-20
Last updated
2017-06-28

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT03192592. Inclusion in this directory is not an endorsement.

Safety and Effectiveness Evaluation of the Apotech® Diabetic Body Moisturizer (NCT03192592) · Clinical Trials Directory